Teva Pharmaceutical Industries Limited Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (380)

Latest Posts

About This Stock More About This Stock
18 Drugs To Lose Patents In 2017; Could Jeopardize $26.5B For Big Pharma
Article By: Lorimer Wilson
Saturday, April 22, 2017 8:24 PM EDT
With 18 branded drugs on the line, patent losses this year could jeopardize $26.5 billion in annual sales from Big Pharma, projected to be the biggest fall-off until at least 2025.
In this article: AZN, BMY, GSK, LLY, MRK, PFE, SNY, RHHBY, TEVA
Read
Better Big Pharma Dividend Stock: Pfizer Or Teva?
Article By: SureDividend
Wednesday, April 19, 2017 11:44 AM EDT
Teva has a very low valuation, and a solid dividend yield. Pfizer has a more secure dividend. And, its dividend is not subject to any withholding tax.
In this article: PFE, TEVA Also: VRX, JNJ
Read
Neurocrine Bioscience Receives FDA Approval For Ingrezza For Treatment Of TD; Stock Jumps 19%
Article By: Lorimer Wilson
Tuesday, April 11, 2017 10:14 PM EDT
Neurocrine Bioscience, Inc. has received FDA approval for its branded drug Ingrezza (valbenazine) for the treatment of tardive dyskinesia, setting up a potential showdown with Teva and its rival therapy.
In this article: NBIX, TEVA
Read
Teva Pharmaceutical Receives FDA Approval For A Deuterated Drug (A First) For The Treatment Of Huntington’s Chorea
Article By: Lorimer Wilson
Tuesday, April 4, 2017 10:05 AM EDT
Teva Pharmaceutical Industries Limited has received FDA approval for deutetrabenazine - the first FDA approval in the world of deuterated drugs - for the treatment of Huntington’s chorea.
In this article: TEVA
Read
Teva Pharmaceutical Industries Ltd. In Turmoil, Plans To Cut 11% Of Its Workforce After Passover
Article By: Lorimer Wilson
Thursday, March 23, 2017 10:17 AM EDT
With its executive suite in turmoil, its flagship drug under attack and its books burdened by debt following years of drought in its R&D arm, TEVA is reportedly preparing to unleash a major reorganization that will cost thousands of jobs.
In this article: TEVA Also: AGN
Read

PARTNER HEADLINES

Latest Tweets for $TEVA

No tweets yet!

$TEVA

Teva Surprised On The Upside Today; Reporting Q4 Sales Of $6.5 Billion
Ayelet Wolf 2/13/2017 9:33:07 PM

A nice bounce for #Teva. Happy to see such gains after the recent turmoil, $TEVA

Teva CEO Vigodman Is Out
Donald Kaplan 2/7/2017 12:05:20 AM

#Vigodman was killing #Teva. This is good news for the stock. $TEVA!

Teva CEO Vigodman Is Out
Ayelet Wolf 2/7/2017 12:02:32 AM

Someone who was born in Israel. I agree with the author that #Teva should be looking first at who can best fill the CEO role regardless of where he or she is from. $TEVA

Teva CEO Vigodman Is Out
Alexa Graham 2/7/2017 12:01:20 AM

Thanks for breaking this big news about $TEVA! But what's a sabra?

1 to 4 of 4 comments